Arcturus Therapeutics Holdings (ARCT) Long-Term Investments (2018 - 2022)

Arcturus Therapeutics Holdings has reported Long-Term Investments for 5 years, with the latest figure at $131000.0 in Q1 2022.

• For the quarter ending Q1 2022, Long-Term Investments fell 89.5% year-over-year to $131000.0; the trailing twelve-month figure through Mar 2022 stood at $131000.0 (down 89.5% YoY), and the FY2021 full-year result was $515000.0, changed N/A from the prior year.
• Long-Term Investments for Q1 2022 stood at $131000.0, down from $515000.0 in the prior quarter.
• The five-year high for Long-Term Investments was $1.2 million in Q1 2021, with the low at $100000.0 in Q1 2020.
• Historically, Long-Term Investments has averaged $493111.1 across 5 years, with a median of $303000.0 in 2019.
• Annual changes were most pronounced in 2021 — Long-Term Investments jumped 1148.0% — and 2022, when it plunged 89.5%.
• Arcturus Therapeutics Holdings' Long-Term Investments stood at $288000.0 in 2018, then fell by 8.68% to $263000.0 in 2019, then slumped by 61.98% to $100000.0 in 2020, then soared by 415.0% to $515000.0 in 2021, then sank by 74.56% to $131000.0 in 2022.
• The last three Long-Term Investments figures came in at $131000.0 (Q1 2022), $515000.0 (Q4 2021), and $670000.0 (Q3 2021), per Business Quant data.